X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3839) 3839
Book Chapter (25) 25
Magazine Article (22) 22
Newsletter (12) 12
Conference Proceeding (4) 4
Dissertation (4) 4
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3157) 3157
isoniazid - adverse effects (2033) 2033
male (1756) 1756
female (1677) 1677
science & technology (1480) 1480
adult (1421) 1421
life sciences & biomedicine (1371) 1371
isoniazid - therapeutic use (1338) 1338
isoniazid (1145) 1145
tuberculosis (1081) 1081
middle aged (1072) 1072
antitubercular agents - adverse effects (899) 899
tuberculosis, pulmonary - drug therapy (884) 884
antitubercular agents - therapeutic use (701) 701
isoniazid - administration & dosage (659) 659
aged (634) 634
rifampin - adverse effects (632) 632
abridged index medicus (615) 615
adolescent (577) 577
rifampin - therapeutic use (567) 567
drug therapy, combination (548) 548
tuberculosis - drug therapy (515) 515
child (412) 412
antitubercular agents - administration & dosage (401) 401
rifampin - administration & dosage (385) 385
infectious diseases (384) 384
chemical and drug induced liver injury - etiology (383) 383
animals (351) 351
rifampin (300) 300
treatment outcome (298) 298
ethambutol - therapeutic use (296) 296
drug therapy (292) 292
risk factors (281) 281
time factors (281) 281
general & internal medicine (279) 279
liver - drug effects (265) 265
pharmacology & pharmacy (261) 261
tuberculosis - prevention & control (256) 256
respiratory system (245) 245
old medline (240) 240
child, preschool (237) 237
ethambutol - adverse effects (226) 226
medicine, general & internal (222) 222
streptomycin - therapeutic use (218) 218
antitubercular agents (212) 212
pyrazinamide - therapeutic use (212) 212
pyrazinamide - adverse effects (210) 210
infant (201) 201
streptomycin - adverse effects (201) 201
tuberculin test (182) 182
health aspects (181) 181
mycobacterium tuberculosis - drug effects (181) 181
retrospective studies (181) 181
drug administration schedule (177) 177
research (175) 175
care and treatment (174) 174
immunology (174) 174
drug resistance (172) 172
young adult (172) 172
research article (171) 171
tuberculosis, pulmonary - prevention & control (168) 168
pyrazinamide (166) 166
pyrazinamide - administration & dosage (166) 166
patients (163) 163
niacin (161) 161
ethambutol - administration & dosage (159) 159
chemical and drug induced liver injury (158) 158
microbiology (156) 156
medicine (155) 155
drugs (153) 153
drug interactions (151) 151
hepatotoxicity (150) 150
nicotinic acids - adverse effects (149) 149
infections (146) 146
isoniazid - pharmacology (141) 141
human immunodeficiency virus--hiv (139) 139
mycobacterium tuberculosis (138) 138
analysis (135) 135
prospective studies (133) 133
latent tuberculosis - drug therapy (131) 131
rats (131) 131
follow-up studies (130) 130
drug resistance, microbial (123) 123
mycobacterium tuberculosis - isolation & purification (123) 123
liver (122) 122
hiv (120) 120
isoniazid - toxicity (118) 118
ethambutol (117) 117
isoniazid - metabolism (116) 116
tuberculosis - epidemiology (114) 114
dosage and administration (113) 113
streptomycin - administration & dosage (113) 113
drug combinations (111) 111
patient compliance (111) 111
aged, 80 and over (110) 110
aminosalicylic acids - adverse effects (110) 110
pregnancy (109) 109
sputum - microbiology (109) 109
age factors (107) 107
antitubercular agents - pharmacology (106) 106
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3084) 3084
French (222) 222
German (217) 217
Russian (104) 104
Japanese (99) 99
Spanish (70) 70
Italian (60) 60
Polish (49) 49
Portuguese (35) 35
Chinese (19) 19
Dutch (16) 16
Norwegian (12) 12
Romanian (12) 12
Czech (8) 8
Korean (5) 5
Danish (4) 4
Hungarian (4) 4
Bulgarian (3) 3
Finnish (3) 3
Hebrew (3) 3
Swedish (2) 2
Turkish (2) 2
Breton (1) 1
Croatian (1) 1
Persian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs (New York, N.Y.), ISSN 0012-6667, 2007, Volume 67, Issue 1, pp. 75 - 93
This article reviews several retrospective case series and reported adverse events regarding common ocular adverse effects related to systemic therapy... 
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Eye Diseases - chemically induced | Phytotherapy - adverse effects | Drug-Related Side Effects and Adverse Reactions | Humans | Index Medicus
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2010, Volume 33, Issue 5, pp. 371 - 391
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2012, Volume 56, Issue 6, pp. 3027 - 3031
Journal Article
Nature medicine, ISSN 1078-8956, 04/2013, Volume 19, Issue 4, pp. 418 - 420
Journal Article